GGrantIndex
← Search

PRODUCTION OF VARIOUS STRENGTH OF INJECTABLE LMP744 FOR CLINICAL USE; POP: 02/14/2020 - 02/13/2021

$512,500N02FY2020CANIH

Irisys, Inc., San Diego CA

Investigators

Abstract

The Contractor will manufacture injectable LMP744 at various strength under cGMP condition for clinical use including one base year and four (4) one-year options during the next five years.

View original record on NIH RePORTER →